Search

everythinglearnresearchcommunity

for

Search:↓

Natural volatiles and essential oils have health benefits and can enhance the effects of some medicines, but more research is needed to understand how they work and their possible side effects.

JAK inhibitors show promise for treating various skin diseases.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

PTH-CBD could help prevent and treat hair loss caused by chemotherapy in mice.

Tempol is safe and may prevent hair loss from brain radiotherapy.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

Finasteride use is not clearly linked to an increased risk of male breast cancer.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Removing lymph nodes does not improve survival for advanced ovarian cancer and may cause more complications.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Dermatologists should carefully manage hair loss in cancer patients to improve their quality of life.

Scalp cooling and low-power light therapy show promise in reducing chemotherapy-induced hair loss but need more research.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Cooling the scalp below 22°C before and during chemotherapy can help prevent hair loss.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Tamoxifen caused hair loss in a 52-year-old woman.

Higher DHT in male baldness may protect against prostate cancer.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Septin4 helps kill colon cancer cells by working with the protein BAX.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.